Feedback from the Heart Rhythm Society meeting suggests 50% to 70% of physicians could adopt the procedure “right out of the gate,” said Truist analyst Richard Newitter.

Diabetes tech companies shared updates on new products, largely focused on Type 2 patients, in Q1 earnings calls.

Megadyne discontinued the product globally after receiving four reports of patients being burned in procedures where the electrode pads were used.

Cybersecurity group Nozomi Networks Labs identified 11 vulnerabilities across several systems and software in an investigation of imaging machines.

The partners are developing a robotically steered diagnostic catheter for use with Stereotaxis’ cardiovascular robots.

For medical products, the tariff increases focus on syringes, face masks and gloves — areas where the U.S. has sought to ramp up domestic production after the start of the pandemic. The U.S. imported ...

Officials moved to stop the plastic syringes made by two Chinese manufacturers from entering the U.S. after finding quality system failings.

Patients can self-collect the samples in locations such as retail pharmacies, which could encourage more people to get tested.

In the latest notice, which follows a February recall of the device for a separate issue, Abbott took action due to reports of blood leakage and air entrapment.

In addition to the partnership announcements, Dr Sharp also celebrated the one year anniversary of the launch of the Galvan+ ...

CEO Mattias Perjos said the action will have “some negative financial impact,” but the total effect will depend on customers' response.

Michelle Tarver, an FDA official, said a new program is meant to advance health equity by considering people’s living conditions as part of medical device design.